Concepedia

A.-E. Roske

AR

Statistics

Publications

8

Citations

1.7K

H-Index

8

Active since

2008

Affiliations

Charité - Universitätsmedizin Berlin(Current)

University Hospital of Zurich

Siemens (Germany)

A.-E. Roske is an author at Charité - Universitätsmedizin Berlin specializing in medicine, oncology, and molecular oncology.

Publications per year

2008–2009

8

Publications

8

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

Wilko Weichert, A.-E. Roske, Volker Gekeler et al. · British Journal of Cancer · 2008 · 479 citations · Full text

Medicine, Molecular Biology, Oncology +17

Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases <i>In vitro</i> and <i>In vivo</i>

Wilko Weichert, A.-E. Roske, Silvia Niesporek et al. · Clinical Cancer Research · 2008 · 371 citations

Medicine, Molecular Biology, Oncology +15

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis

Wilko Weichert, A.-E. Roske, Volker Gekeler et al. · The Lancet Oncology · 2008 · 362 citations

Medicine, Molecular Biology, Oncology +16

Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer

Aurelia Noske, Wilko Weichert, Silvia Niesporek et al. · Cancer · 2008 · 214 citations · Full text

Medicine, Cancer Biology, Oncology +13

Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer

Florian Fritzsche, Wilko Weichert, A.-E. Roske et al. · BMC Cancer · 2008 · 164 citations · Full text

Medicine, Oncology, Pharmacology +12

1–5 of 8